Summary
  • Multi-target molecules 315
  • Clinical molecules 0
  • Avg pChEMBL 7.76
Top Co-occurrence Targets
Active Molecules (315)
InChIKey pChEMBL Type Targets Clinical
MMEBEYJGRMEXOT 7.8 IC50 4
PUQQQYPELOIWQD 7.8 Ki 2
SGHJJLBGKZIPSW 7.8 IC50 4
VZZMJPCOMQVXJP 7.8 Ki 2
YQRXHHYPBWDIBF 7.8 Ki 2
AXWMDGHQDHNMNA 7.8 Ki 2
GBEBMXGNSZYQLY 7.8 Ki 2
MSHRDJHOMYCZBB 7.8 Ki 2
HXXVITOQQVLVOJ 7.8 Ki 2
VRKCKWLSJXJKQS 7.8 Ki 3
CCCPJDHTMQAJPJ 7.7 Ki 2
LUMMUNDAQFULAJ 7.7 IC50 4
NPQDEJXAMYXBRX 7.7 Ki 2
AFTKZUHBECRIPD 7.7 IC50 4
BHALKRHIAOUWNH 7.7 IC50 3
DTAGYFFAIVVJHG 7.7 IC50 4
JQBKYSQXCVMPJQ 7.7 Ki 2
JRBOXXSEYWPYMG 7.7 IC50 4
NAEFTBYPSLMAJV 7.7 IC50 4
QDLVNWRFJITDTF 7.7 IC50 4
QUTJDLPIJGFVTJ 7.7 IC50 4
UVNAIHPALNWIGA 7.7 IC50 4
XQWARQVHEJRBID 7.7 IC50 4
NUCHWCYHUPYULI 7.7 Ki 2
WJDPCWFIKAZSPS 7.7 Ki 2
QFVVLWTXDCYIMN 7.7 IC50 4
BXZYHWGQDBDZKB 7.6 IC50 4
GQDQSRGJEOLULH 7.6 Ki 2
JFFCCDKBNGGOOE 7.6 IC50 4
MJXQFUHPNRVFRD 7.6 IC50 4
NSGBTQBHUVVQQK 7.6 IC50 4
RFBAMGIPTJOMSX 7.6 IC50 4
UOZVLIAVHBKHOK 7.6 IC50 4
YBTBVSQNDKHMPU 7.6 IC50 4
OGQBSZUAEHZESX 7.6 Ki 2
YOSDIEMVUOHXLT 7.6 Ki 2
XIPVCPAVHZMILG 7.6 Ki 2
IANDMVKFJFCVEI 7.5 Ki 2
KHJUFJPLFNKMMO 7.5 IC50 4
PPLIHRDWIUFUOR 7.5 IC50 4
SFKSPKKZUGZHGG 7.5 IC50 4
VFFWWNSXYHEQFM 7.5 IC50 4
GHDPNYZUGAGWJK 7.5 IC50 4
KEYZYISKCGSJQI 7.5 IC50 4
LXTJVTZCNTYRMW 7.5 IC50 4
NAEFTBYPSLMAJV 7.5 IC50 4
PHOYHEJCIQOPQC 7.5 Ki 2
QLSVUCOWXZXLOJ 7.5 IC50 4
FNJOFQOOHOPNIY 7.4 Ki 3
AQILAUSZMZFFOH 7.4 IC50 4
2D structure